A detailed history of Inscription Capital, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Inscription Capital, LLC holds 2,015 shares of DXCM stock, worth $137,241. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,015
Previous 2,000 0.75%
Holding current value
$137,241
Previous $277,000 17.69%
% of portfolio
0.04%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

BUY
$110.31 - $140.45 $1,654 - $2,106
15 Added 0.75%
2,015 $228,000
Q4 2023

Jan 18, 2024

BUY
$75.49 - $124.16 $150,980 - $248,320
2,000 New
2,000 $248,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $26.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Inscription Capital, LLC Portfolio

Follow Inscription Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inscription Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inscription Capital, LLC with notifications on news.